Medicine and Dentistry
COVID-19
100%
Infection
33%
Human Immunodeficiency Virus
31%
Comorbidity
27%
Pericarditis
26%
Diseases
21%
Prevalence
19%
Health Care Personnel
17%
Diabetes
15%
Drug Resistance
14%
Sepsis
13%
Tocilizumab
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Serositis
13%
Low Drug Dose
13%
Cohort Analysis
13%
Pneumococcus Vaccine
13%
Immunoglobulin G Antibody
13%
Population Research
13%
Resistance Mutation
13%
Symptomatic Treatment
13%
Antibiotic Resistance
13%
Virus Nucleocapsid
13%
Streptococcus Pneumonia
13%
Noninferiority Trial
13%
Lung
13%
Seroprevalence
13%
Rilpivirine
13%
Cabotegravir
13%
Pneumococcal Pneumonia
13%
Radiation Therapy
13%
Oral
13%
Artificial Respiration
11%
Antibiotics
9%
Placebo
8%
Non Communicable Disease
8%
Odds Ratio
8%
Disability Adjusted Life Years
8%
Treatment Outcome
8%
Coughing
7%
Group Therapy
7%
Intensive Care
6%
Acute Respiratory Failure
6%
Tamponade
6%
Health Care
6%
Constrictive Pericarditis
6%
Respiratory Failure
6%
Combination Therapy
6%
Polymerase Chain Reaction
6%
Primary Outcome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
60%
HIV
42%
Histoplasmosis
39%
Comorbidity
32%
Prevalence
32%
Infection
26%
Sepsis
26%
Combination Therapy
18%
Cohort Study
13%
Coronavirinae
13%
Tocilizumab
13%
SARS Coronavirus
13%
Pneumococcus Vaccine
13%
Immunoglobulin G Antibody
13%
Ferritin
13%
Systemic Treatment
13%
Acute Toxicity
13%
Phase II Trials
13%
Clinical Trial
13%
D Dimer
13%
Drug Resistance
13%
Dexamethasone
13%
Cytokine Storm
13%
Seroprevalence
13%
Streptococcus Pneumonia
13%
Antibiotic Resistance
13%
Placebo
8%
Non Communicable Disease
8%
Antibiotics
6%
Coughing
6%
Mixed Infection
5%
Disease Severity
5%
Nursing and Health Professions
COVID-19
34%
Comorbidity
27%
Tertiary Care Center
26%
Health Care Personnel
17%
Severe Acute Respiratory Syndrome
15%
Cohort Analysis
13%
Pneumococcal Conjugate Vaccine
13%
Immunoglobulin G Antibody
13%
Histoplasmosis
13%
Seroprevalence
13%
Sepsis
13%
Streptococcus Pneumonia
13%
Antibiotic Resistance
13%
Confidence Interval
10%
Infection
8%
Non Communicable Disease
8%
Odds Ratio
8%
Disability-Adjusted Life Year
8%
Diseases
8%
Human Immunodeficiency Virus
6%
Prevalence
5%